5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between diastolic blood pressure (DBP) ≥90 mmHg and efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving axitinib (Ag-013736; Ag)
    Meeting Abstract

    Rixe, O.; Dutcher, J. P.; Motzer, R. J.; Wilding, G.; Stadler, W. M.; Kim, S.; Tarazi, J.; Rosbrook, B.; Rini, B.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Wong, B. Y.; Ross, R. W.; George, D. J.; Picus, J.; Atadja, P.; Yang, W.; Culver, K. W.; Woo, M. M.; Scher, H. I.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Sunitinib as first-line treatment for metastatic renal cell carcinoma (MRCC): Updated results and analysis of prognostic factors from a phase III randomised trial
    Meeting Abstract

    Oudard, S.; Motzer, R. J.; Michaelson, M. D.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixie, O.; Negrier, S.; Kim, S. T.; Chen, J.; more...
    European Urology, Supplements (2008)

    Fulltext@MSK | Save
  • Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (MRCC)
    Meeting Abstract

    Negrier, S.; Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Huang, X.; Kim, S. T.; Chen, I.; Motzer, R. J.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Tanespimycin (17-allylamino-17-demethoxy-geldanamycin; 17-AAG) in breast cancer
    Meeting Abstract

    Modi, S.; Sugarman, S.; Stopeck, A.; Linden, H.; Ma, W.; Chandarlapaty, S.; Solit, D.; Norton, L.; Rosen, N.; Kersey, K.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Sunitinib versus interferon-alpha for first-line treatment of metastatic renal cell carcinoma: Updated results and further prognostic factor analyses
    Meeting Abstract

    Grünwald, V.; Eberhardt, W.; Ringhoffer, M.; Jakse, G.; Motzer, R. J.
    Onkologie (2008)

    Fulltext@MSK | Save
  • Phase-3 randomised trial of everolimus (RAD001) vs placebo in metastatic renal cell carcinoma
    Meeting Abstract

    Escudier, B.; Ravaud, A.; Oudard, S.; Hutson, T. E.; Porta, C.; Bracarda, S.; Grünwald, V.; Thompson, J.; Figlin, R. A.; Motzer, R. J.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Levothyroxin treatment of hypothyroidism and axitinib (Ag-013736) efficacy in patients (PTS) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Dutcher, J. P.; Rixe, O.; Motzer, R. J.; Wilding, G.; Stadler, W. M.; Kim, S.; Tarazi, J.; Rosbrook, B.; Rini, B.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • An updated geographic subpopulation analysis of health-related quality of life (HRQOL) in patients with metastatic renal cell carcinoma (MRCC) enrolled in a phase III trial of sunitinib versus interferon-alfa
    Meeting Abstract

    Cella, D.; Bushmakin, A. G.; Cappelleri, J. C.; Kim, S. T.; Motzer, R. J.; Charbonneau, C.
    Value in Health (2008)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQOL) in metastatic renal cell carcinoma (mRCC) patients receiving sunitinib (SU) or interferon (IFN)-alfa in a randomized phase III trial: Updated geographic analysis
    Meeting Abstract

    Cella, D.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Li, J. Z.; Kim, S. T.; Motzer, R. J.
    Annals of Oncology (2008)

    Fulltext@MSK | Save